Nabi Sells Biologics Business To German Plasma Protein Firm Biotest
This article was originally published in The Pink Sheet Daily
Executive Summary
Nabi met with FDA Sept. 11 concerning components and a timeline for completion of its Nabi-HB IV BLA, pending at the agency since 2002.